132 results
Page 3 of 7
8-K
EX-99.2
q00a6cytz3g7
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
vlygg tzcci
12 Sep 22
Departure of Directors or Certain Officers
7:05am
8-K
EX-99.2
xkawe7a077e4cw59kcm
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
8-K
EX-10.1
1kool e41vwkang7ysuo
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
s1w4hketxik5c
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
DEFA14A
7otsjyb 8y6ms7b7uhg
31 May 22
Additional proxy soliciting materials
4:03pm
8-K
EX-10.1
c5wjk792ins5y
31 May 22
Departure of Directors or Certain Officers
4:03pm
8-K
zn66fe77ee9gyauikh3
31 May 22
Departure of Directors or Certain Officers
4:03pm
DEFA14A
221m aiyk6ie
18 May 22
Additional proxy soliciting materials
4:03pm
8-K
EX-10.1
33p09x0 ac
16 May 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-10.2
bung2kt0 ujwzpm
16 May 22
Departure of Directors or Certain Officers
7:26am
8-K
ezraeurbx049s77guo
16 May 22
Departure of Directors or Certain Officers
7:26am
8-K
EX-99.1
yu814vr4
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.2
jizkqkv8t vroaf
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm